EIT Health Looks to Create New Business Ventures Addressing the Way we Manage Mental and Brain Health and Use Digital Biomarkers for Diagnostics

EITEIT Health, a network of best-in-class innovators backed by the EU, has announced the second year of its innovation programme, Wild Card. The second year of high-risk innovation programme Wild Card kicks off this week, challenging talent to deliver real solutions to the healthcare market.

  • EIT Health Wild Card programme application window open until 10 February 2019, looking for entrepreneurs, scientists, medical professionals, technical experts and researchers.
  • Successful applicants will be shortlisted for 2019 hackathon where they will fight for business support and funding.
  • Winning teams will receive world class business mentoring and €2 million in funding over two years.
  • Jan-Philipp Beck, EIT Health CEO: "We know this talent is out there... through this programme, we hope to bring their ideas to the next level."

Individuals will be taken on an entrepreneurial journey to become high-performing teams transforming their idea into a healthcare product or solution, thanks to the world class business mentoring, coaching and networking opportunities provided throughout four-phase innovation programme, Wild Card.

This year, Wild Card will focus on two challenges: mental and brain health and digital biomarkers in diagnostics.

The programme will build momentum through a week-long hackathon in April 2019 determining which ideas are selected to go through to the next phases; including a business acceleration and mentoring programme, and a final pitching round.

The ultimate goal of Wild Card is to create two new ventures and award them two years of support and €2 million in non-dilutive funding, helping them grow their high-risk ideas into thriving commercial businesses.

Each year, Wild Card sets down different challenges to the innovation community. Last year’s programme resulted in the development of two projects tackling the areas of antibiotic resistance and the use of data to enhance diagnostics: DX-Labtrack and Abtrace. These two newly-created start-ups will work with EIT Health over the next two years to accelerate their products towards market-readiness.

Wild Card is now offering the opportunity for new applicants to join the programme, looking at two major key issues that impact citizens' health in Europe. This year's hopeful candidates must present their experience, skills and ideas to address one of two questions:

  • Mental and brain health - How to improve prediction, diagnosis and treatment to fight mental disorders and strengthen brain health?
  • Digital biomarkers - How to improve early diagnostics with the application of digital biomarkers?

Commenting at the Wild Card programme application launch, EIT Health's CEO Jan-Philipp Beck said: "Now in its second year, Wild Card continues its search for risk-taking game changers who have the potential to bring about transformations in healthcare. We know this talent is out there and looking for the right opportunities. Through this programme, we hope to find them and offer them the business, research and financial supports necessary to bring their ideas to the next level."

Applications can be submitted via wildcard.eithealth.eu from 10 December 2018. The deadline for applications is 23:59 CET (Central European Time), 10 February 2019.

About the Wild Card programme

Wild Card is a game-changing health innovation programme pioneered by EIT Health. Each year, Wild Card sets out different healthcare challenge areas, with the goal of delivering solutions to enable European citizens to live longer, healthier lives. Focusing on applied research, entrepreneurial ideas and innovative thinking, Wild Card takes a venture-building approach that identifies, fosters and helps develop high-risk ideas into thriving commercial businesses.

Through this unique programme, EIT Health offers world class mentors and business coaches to equip participants with the knowledge and expertise necessary to start on the right path; supports and accelerates the formation of skilled and ambitious teams by facilitating connections with other like-minded innovators; and funds these teams on their journey, from ideation to start-up incorporation.

About EIT Health

EIT Health is a network of best-in-class health innovators backed by the EU. We collaborate across borders to deliver new solutions that can enable European citizens to live longer, healthier lives.

As Europeans tackle the challenge of increasing chronic diseases and multi-morbidity, and seek to realise the opportunities that technology offers to move beyond conventional approaches to treatment, prevention and healthy lifestyles, we need thought leaders, innovators and efficient ways to bring innovative healthcare solutions to market.

EIT Health addresses these needs. We connect all relevant healthcare players across European borders - making sure to include all sides of the "knowledge triangle", so that innovation can happen at the intersection of research, education and business for the benefit of citizens.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...